Výsledky vyhledávání - "Olesen, J. B."

The individual stroke risk in patients with atrial fibrillation

Autor: Lee, C.J.-Y, Ozenne, B, Olesen, J B, Gislason, G, Torp-Pedersen, C, Gerds, T A

Publikováno v: Lee, CJ-Y, Ozenne, B, Olesen, J B, Gislason, G, Torp-Pedersen, C & Gerds, T A 2018, ' The individual stroke risk in patients with atrial fibrillation ', European Heart Journal Supplements, vol. 39, no. suppl_1, P4817, pp. 1013 . https://doi.org/10.1093/eurheartj/ehy563.P4817

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5f2cbf83c45307f86ad2ea61b35e8829
https://vbn.aau.dk/da/publications/c109a118-6adb-4576-b377-9431a1434cdd

Zobrazit plný text záznamu

Oral anticoagulants in patients with atrial fibrillation and non-mechanical heart valve disease

Autor: Strange, J E, Sindet-Pedersen, C, Staerk, L, Gislason, G H, Torp-Pedersen, C, Olesen, J B

Publikováno v: Strange, J E, Sindet-Pedersen, C, Staerk, L, Gislason, G H, Torp-Pedersen, C & Olesen, J B 2018, ' Oral anticoagulants in patients with atrial fibrillation and non-mechanical heart valve disease ', European Heart Journal Supplements, vol. 39, no. suppl_1, P6076, pp. 1266 . https://doi.org/10.1093/eurheartj/ehy566.P6076

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3b044bf278686cc0179429aa506b0d3d
https://vbn.aau.dk/da/publications/fcc5a70d-debf-49b5-ad6f-d0d9fc363949

Zobrazit plný text záznamu

Autor: Butt, Jawad H., Rorth, R., Gundlund, A., Olesen, J. B., Gislason, G. H., Torp-Pedersen, Christian, Kober, L., Fosbol, E. L.

Publikováno v: Butt, J H, Rorth, R, Gundlund, A, Olesen, J B, Gislason, G H, Torp-Pedersen, C, Kober, L & Fosbol, E L 2017, ' Similar long-term risk of thromboembolic events in postoperative atrial fibrillation following coronary artery bypass grafting and non-valvular atrial fibrillation : need for anticoagulation? ', European Heart Journal, vol. 38, no. Suppl. 1, 5717 . https://doi.org/10.1093/eurheartj/ehx493.5717

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::95859cbafc1d7add19cd2da5541b1180
https://vbn.aau.dk/da/publications/38b425cc-8d14-4bea-a635-f8fe28db3087

Zobrazit plný text záznamu

Dabigatran, rivaroxaban, and apixaban versus vitamin K antagonists for atrial fibrillation patients at low to intermediate stroke risk:a Danish nationwide cohort study

Autor: Dukanovic, A., Staerk, L., Fosbol, E. L., Sindet-Pedersen, C., Bonde, A. N., Lorentzen, A. G., Gislason, G. H., Torp-Pedersen, Christian, Olesen, J. B.

Publikováno v: Dukanovic, A, Staerk, L, Fosbol, E L, Sindet-Pedersen, C, Bonde, A N, Lorentzen, A G, Gislason, G H, Torp-Pedersen, C & Olesen, J B 2017, ' Dabigatran, rivaroxaban, and apixaban versus vitamin K antagonists for atrial fibrillation patients at low to intermediate stroke risk : a Danish nationwide cohort study ', European Heart Journal, vol. 38, no. Suppl. 1, P3596, pp. 770 . https://doi.org/10.1093/eurheartj/ehx504.P3596

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::df675d9d631a5806d62aa7093e318a31
https://vbn.aau.dk/da/publications/982b3109-2df7-4a40-a7ba-1fc7879424b6

Zobrazit plný text záznamu

Pre- and post-stroke antithrombotic therapy in atrial fibrillation patients:a Danish nation-wide registry-based study

Autor: Gundlund, A., Xian, Y., Peterson, E. D., Butt, J., Gadsboell, K., Olesen, J. B., Koeber, L., Torp-Pedersen, Christian, Gislason, G. H., Fosboel, E. L.

Publikováno v: Gundlund, A, Xian, Y, Peterson, E D, Butt, J, Gadsboell, K, Olesen, J B, Koeber, L, Torp-Pedersen, C, Gislason, G H & Fosboel, E L 2017, ' Pre-and post-stroke antithrombotic therapy in atrial fibrillation patients : a Danish nation-wide registry-based study ', European Heart Journal, vol. 38, no. Suppl. 1, P4308, pp. 884 . https://doi.org/10.1093/eurheartj/ehx504.P4308

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::681b7d450c36ffbb400748e5b807d3fc
https://vbn.aau.dk/da/publications/87381f46-f662-46c7-954d-27fe5929c671

Zobrazit plný text záznamu

Shifting from vitamin K antagonist to dabigatran in atrial fibrillation:differences according to dose

Autor: Vinding, N. E., Staerk, L., Gislason, G., Torp-Pedersen, Christian, Bonde, A. N., Roerth, R., Olesen, J. B., Koeber, L., Fosboel, E. L.

Publikováno v: Vinding, N E, Staerk, L, Gislason, G, Torp-Pedersen, C, Bonde, A N, Roerth, R, Olesen, J B, Koeber, L & Fosboel, E L 2017, ' Shifting from vitamin K antagonist to dabigatran in atrial fibrillation : differences according to dose ', European Heart Journal, vol. 38, no. Suppl. 1, P2687, pp. 576 . https://doi.org/10.1093/eurheartj/ehx502.P2687

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f5577cc7d7941daf21191c64090569db
https://vbn.aau.dk/da/publications/e716a9c5-f451-411d-a301-c7cec304637e

Zobrazit plný text záznamu

Outcomes in vitamin K antagonist treated atrial fibrillation patients with stable international normalized ratios

Autor: Bonde, A. Nissen, Staerk, L., Gislason, G., Torp-Pedersen, Christian, Lip, Gregory Y.H., Olesen, J. B.

Publikováno v: Bonde, A N, Staerk, L, Gislason, G, Torp-Pedersen, C, Lip, G Y H & Olesen, J B 2017, ' Outcomes in vitamin K antagonist treated atrial fibrillation patients with stable international normalized ratios ', European Heart Journal, vol. 38, no. Suppl. 1, P4016, pp. 838-839 . https://doi.org/10.1093/eurheartj/ehx504.P4016

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5de3e1b683e5187faeba07b3a51fa3d4
https://vbn.aau.dk/da/publications/197430a2-d89d-43c9-b8c8-9d2728046e7c

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání